Kailera Therapeutics, Inc. KLRA
12.97 USD +0.80 (+6.57%)
At closeNov 6, 2026, 6:22 PM EST
13.31 +0.34 +2.62%
After hours · Nov 6, 6:22 PM ET
11.97 Day range 13.26
10.00 52-week range 26.00
- YTD
- -50.12%
- 1 year
- -50.12%
Financial health
Rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -20.6×
FY 2025 5y median -20.6× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -8.6×
FY 2025 5y median -8.6× FY 2025
P/FCF -25.1×
FY 2025 5y median -25.1× FY 2025
EV/EBITDA -18.5×
FY 2025 5y median -18.5× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -4.0%
FY 2025 5y median -4.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 41.8%
FY 2025 5y median 41.8% FY 2025
ROIC -24.5%
FY 2025 5y median -24.5% FY 2025
ROA -21.5%
FY 2025 5y median -21.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 12.0×
FY 2025 5y median 12.0× FY 2025
Quick Ratio 12.0×
FY 2025 5y median 12.0× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2025 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31